Drljevic-Nielsen, Aska
Mains, Jill R.
Thorup, Kennet
Andersen, Michael Brun
Rasmussen, Finn
Donskov, Frede
Funding for this research was provided by:
Ipsen
Article History
Received: 17 December 2021
Revised: 30 March 2022
Accepted: 3 April 2022
First Online: 5 May 2022
Declarations
:
: The scientific guarantor of this publication is Finn Rasmussen.
: Aska Drljevic-Nielsen reports a research grant from Ipsen and teaching fees from Philips. Frede Donskov reports research grants from Ipsen, Pfizer, MSD, and The Health Research Foundation, Central Denmark Region. Michael Brun Andersen reports teaching fees from Philips and Boehringer Ingelheim. No potential conflicts of interest were disclosed by the other authors.
: No complex statistical methods were necessary for this paper.
: Written informed consent was obtained from all patients in this study.
: The Regional Ethics Committee and Regional Data Protection Agency approved the study. Informed written consent was obtained prior to inclusion.
: Association of baseline data with patient outcomes in this patient group has been analyzed separately and has been accepted for publication in AJR (currently <i>in press</i>). This is also noted in the methods section of the manuscript.
: • Prospective• Observational• Performed at one institution